期刊文献+

局限期小细胞肺癌胸部放疗及放射损伤的研究现状 被引量:9

Current research of thoracic radiotherapy and radiation injury on limited small cell lung cancer
下载PDF
导出
摘要 目的:总结国内外局限期小细胞肺癌(LSCLC)胸部放疗研究的现状。方法:应用PubMed和CHKD期刊全文数据库检索系统,以"局限期小细胞肺癌、胸部放疗和放射损伤"为关键词,检索1986-01-2008-04相关LSCLC胸部放疗的文献,共检索到英文文献430篇和中文文献187篇。纳入标准:1)LSCLC胸部放疗的疗效评价;2)LSCLC胸部放疗的方法;3)LSCLC胸部放疗与化疗结合的研究;4)LSCLC胸部放疗损伤的研究。根据纳入标准,精选82篇,最后纳入分析29篇。结果:配合胸部放疗可以提高LSCLC生存期,虽然胸部放疗的剂量、照射范围、分割方式、放化疗的顺序和最佳时机的选择等一直存有争议,但多数专家认为胸部放疗更为合理的方式为早期配合化疗(3个周期内)常规的累及野照射,剂量45~55Gy为宜。这几个热点问题也是引起胸部放疗损伤的重要因素。结论:胸部放疗在LSCLC的治疗中占重要地位,应选择适宜的放疗时机、合理的照射靶区和剂量,给予个体化治疗,以最小的放疗损伤获得最佳的治疗效果。 OBJECTIVE: To conclude current status of thoracic radiotherapy on limited small cell lung cancer. METHODS: By using limited small cell lung cancer, thoracic radiotherapy and radiation injury as key words, the documents about thoracic radiotherapy on limited small cell lung cancer between January 1986 and April 2008 in the PubMed and CHKD full text data base index systems were searched. The data selection: the data about the evaluation of effect and radiation injury of thoracic radiotherapy combined with chemotherapy on limited small cell lung cancer. Standard: 1)effect of radiotherapy on limited small cell lung cancer. 2)methods of radiotherapy on limited small cell lung cancer. 3)radiotherapy combined with chemotherapy for limited small cell lung cancer. 4)injury induced by thoracic radiotherapy on limited small cell lung cancer. According to the standard, 82 essays were selected from hundreds of papers on limited small cell lung cancer, and 28 gone into the analysis in the end. RESULTS: Thoracic radiotherapy can increase the survival of limited small cell lung cancer, but there is argument on when and how to radiate and these are also important factors on radiation injury. Most radiotherapists recommend early concurrent involved field thoracic radiotherapy combined with chemotherapy (within 3 cycles) and a recommended dose of 45 to 55 Gy. CONCLUSION: Thoracic radiotherapy pays a great importance on limited small cell lung cancer, although there are still some disputes about it.
出处 《中华肿瘤防治杂志》 CAS 2008年第17期1353-1356,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 小细胞肺癌/局限期 胸部放疗 放疗损伤 个体化治疗 small cell lung cancer/limited stage thoracic radiotherapy radiation toxicity individual treatment
  • 相关文献

参考文献29

  • 1Walker S. Updates in small cell lung cancer treatment[J]. Clin J Oncol Nurs, 2003,7 (5) : 563-568.
  • 2Komaki R. Combined treatment for limited small cell lung cancer [J]. Semin Oncol,2003,30(4 supple) :56-70.
  • 3Simon G R,Wagner H. Small cell lung cancer[J]. Chest,2003, 123(1 suppl) :259-271.
  • 4Nakanishi Y, Inoue K, Hara N. Trentment of lung cancer-state of the art in 2000[J]. Gan To Kagaku Ryoho, 2000,27(8): 1247-1252.
  • 5吴红宇,周道安,张帆,吴琼雅,马秀梅.局限期小细胞肺癌放化疗综合治疗[J].中国肿瘤,2004,13(2):103-105. 被引量:4
  • 6Curren W J. Combined modality therapy for limited-stage small cell lung caneer[J]. Semin Oneol,2001,28:14 22.
  • 7Merrill R M, Henson D E, Barnes M. Conditional survival among patient with carcinoma of the lung[J]. Chest,1999,116(3) :697- 703.
  • 8Baas P,Belderbos J S, Senan S, et al. Concurrent chemotherepy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a dutch multicenter phase Ⅱ study[J] . Br J Cancer,2006,94(5):625-630.
  • 9Arriagada R, Kramar A, Le Chevalier, et al. Comparing events determining relapse-free survival in limited small cell lung carcinoma. The French Cancer Centers Lung Group[J]. Clin Oncol, 1992,10(3):447-451.
  • 10Bogart J A, Herndon J E , Lyss A P, et al. concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study[J]. Int J Radiat Oncol Biol Phys,2004 ,59(2) :460-468.

二级参考文献43

  • 1蒋月,葛红,单娟.放化早期相伴治疗局限期小细胞肺癌的临床研究[J].中国肿瘤临床与康复,2005,12(3):212-214. 被引量:1
  • 2廖颖曦,李高峰.胸部放疗与放射性肺炎[J].中国肿瘤临床,1997,24(2):149-150. 被引量:7
  • 3中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治规范(第9分册):第2版[M].北京:北京医科大学中国协和医科大学联合出版社,1991.10-15.
  • 4李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 5[1]Parcesh kumar MD. The role of thoracic radiotherapy in the management of limited-stage small cell lung cancer[J]. Chest, 1997, 112:259-265.
  • 6[2]David H,Johnson MD.Management of small cell lung cancer[J]. Chest, 1999,116:525-530.
  • 7[3]Dunst J.Role of radiotherapy in SCLC [J].Lung Cancer,2001,137-141.
  • 8[4]Tsukada H,Yokoyama AG.Concurrent versus sequential RT for SCLC[J].Semi Oncol, 2001,28:23-26.
  • 9[5]Jeremic B, Shibamoto Y, Acimovic L, et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited-stage small-cell lung cancer: a randomized study[J].J Clin Oncol, 1997,15:893-900.
  • 10[7]Takada M, Fukuoka M,Furusek,et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer:results of the Japan Clinical On-cology Group Study 9104 [J].J Clin Oncol,2002,20(14):3054-3060.

共引文献91

同被引文献91

  • 1王颖杰,王绿化,陈东福,周宗玫,欧广飞,梁军,张可,殷蔚伯.小细胞肺癌的三维适形放射治疗[J].中华肿瘤杂志,2005,27(9):570-572. 被引量:12
  • 2王敬慧,马玙.小细胞肺癌的治疗进展评价[J].中国医院用药评价与分析,2007,7(1):11-16. 被引量:4
  • 3Brade AM,Tannock IF.Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer repopulation as a cause of treatment failure[J].J Clin Oncol,2006,24(24):3815.
  • 4De Ruysscher D,Pijls-Johannesma M,Bentzen SM,et al.Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer[J].J Clin Oncol,2006,24:1052.
  • 5Pijls-Johannesma M,De Ruysscher D,Vansteenkiste J,et al.Timing of chest radintherapy in patients with limited stage small cell lung cancer:A systematic review and meta-analysis of randomised controlled trials[J].Cancer Treat Rev,2007,33 (5):461.
  • 6Fried DB,Morris DE,Poole C,et al.Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer[J].Clin Oncol,2004,22 (23):4837.
  • 7De Ruysscher D.Treatment of limited disease small cell lung cancer[J].EurJ Cancer,2009,1:425.
  • 8Takada M,Fukuoka M,Kawahara M,et al.Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage smallcell lung cancer results of the Japan Clinical Oncology Group Study9104[J].J Clin Oncol,2002,20 (14):3054.
  • 9Schild SE,Bonner JA,Hillman S,et al.Results of a phase Ⅱ study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage smallcell lung cancer (NCCTG 95-20-53)[J].J Clin Oncol,2007,25 (21):3124.
  • 10Bayman NA,Sheikha H,Kularatneb B,et al.Radiotherapy for small-cell lung cancer-Where are we heading[J] ? Lung Cancer,2009,63 (3):307.

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部